In an interview with Margot Sanger-Katz of the NY Times, Dr. Gellad discusses Medicare drug pricing. As Ms. Sanger-Katz states, currently private insurance companies seperately negotiate deals on behalf of Medicare patients. What if instead, the government directly negotiated with drug makers? Why does Medicare do a "lousy" job? Read more.